To investigate disease-associated transcriptional changes in pDCs, we purified pDCs from healthy controls (n = 8), At-Risk individuals (n = 4) and SLE patients (n = 13) by negative selection then sorted the cells to achieve purity >99% based on CD304 (BDCA-4) expression. This evidence concerns the gene NRP1 and systemic lupus erythematosus.